In the latest trading session, 2.43 million Protagenic Therapeutics Inc (NASDAQ:PTIX) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $0.90 changing hands around $0.13 or 17.01% at last look, the market valuation stands at $4.03M. PTIX’s current price is a discount, trading about -107.78% off its 52-week high of $1.87. The share price had its 52-week low at $0.49, which suggests the last value was 45.56% up since then. When we look at Protagenic Therapeutics Inc’s average trading volume, we note the 10-day average is 84890.0 shares, with the 3-month average coming to 254.24K.
Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information
Instantly PTIX is in green as seen in intraday trades today. With action 43.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -8.99%, with the 5-day performance at 43.02% in the green. However, in the 30-day time frame, Protagenic Therapeutics Inc (NASDAQ:PTIX) is 69.97% up. Looking at the short shares, we see there were 0.13 million shares sold at short interest cover period of 2.68 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Protagenic Therapeutics Inc (NASDAQ:PTIX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.67% of Protagenic Therapeutics Inc shares while 8.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 10.89%.
